Neurosense Therapeutics Ltd Stock Alpha and Beta Analysis
| NRSNW Stock | USD 0.24 0.06 20.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NeuroSense Therapeutics Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in NeuroSense Therapeutics over a specified time horizon. Remember, high NeuroSense Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NeuroSense Therapeutics' market risk premium analysis include:
Beta (1.12) | Alpha 2.86 | Risk 185.38 | Sharpe Ratio 0.19 | Expected Return 35.27 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NeuroSense |
NeuroSense Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NeuroSense Therapeutics market risk premium is the additional return an investor will receive from holding NeuroSense Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NeuroSense Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NeuroSense Therapeutics' performance over market.| α | 2.86 | β | -1.12 |
NeuroSense Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NeuroSense Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how NeuroSense Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NeuroSense Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how NeuroSense Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuroSense Therapeutics shares will generate the highest return on investment. By understating and applying NeuroSense Therapeutics stock market price indicators, traders can identify NeuroSense Therapeutics position entry and exit signals to maximize returns.
NeuroSense Therapeutics Return and Market Media
The median price of NeuroSense Therapeutics for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 0.17 with a coefficient of variation of 35.67. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 0.17, and mean deviation of 0.04. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | This cheap biotech offers investors a play on ALS if trial data impresses - MarketWatch | 07/02/2024 |
2 | NeuroSense to Present Phase 2b ALS Treatment Trial Results at Major 2024 Symposium NRSN Stock News - StockTitan | 11/21/2024 |
About NeuroSense Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NeuroSense or other stocks. Alpha measures the amount that position in NeuroSense Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2023 | 2024 (projected) | Current Ratio | 19.12 | 0.84 | 0.8 | Net Debt To EBITDA | 3.2 | 0.23 | 0.22 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroSense Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroSense Therapeutics' short interest history, or implied volatility extrapolated from NeuroSense Therapeutics options trading.
Build Portfolio with NeuroSense Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.